Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients
NCT01413815 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 269
Last updated 2022-07-01
Summary
The aim of the study is to test whether pre-operative oral supplementation with L-arginine results in a significant reduction of peri-operative cardiovascular complication rate in unselected patients undergoing major abdominal or thoracic (non-cardiac) surgery. The second aim of the study is to assess whether pre-operative determination of plasma ADMA levels allows to identify patients who are at high risk of experiencing a peri-operative complication, and whether this subgroup of patients profits specifically from pre-operative L-arginine supplementation.
Conditions
- Cardiovascular Complication
Interventions
- DIETARY_SUPPLEMENT
-
L-arginine
3.3 g of L-arginine capsules, oral,b.i.d for a period of three days (a variability ±2 days is accepted to enable scheduling of surgery according to requirements of clinical routine).
- OTHER
-
Placebo
3.3 g of placebo capsules/ b.i.d.; for a period of three days (a variability ±2 days is accepted to enable scheduling of surgery according to requirements of clinical routine)
Sponsors & Collaborators
-
Universitätsklinikum Hamburg-Eppendorf
lead OTHER
Principal Investigators
-
Rainer H. Böger, Professor · Universitätsklinikum Hamburg-Eppendorf
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- Germany
Study Locations
More Related Trials
-
The Role of L-arginine in the Endothelial Dysfunction
NCT00583388 ·Status: WITHDRAWN
-
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
NCT03982160 ·Status: RECRUITING ·Phase: PHASE4
-
Amino Acids for Cardiac Surgery Associated AKI
NCT07001098 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Nitric Oxide Supplementation in Argininosuccinic Aciduria
NCT02252770 ·Status: COMPLETED ·Phase: NA
-
Folic Acid for Prevention of Contrast Induced Nephropathy
NCT02444013 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Serious Adverse Events Following Angiography
NCT01467466 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery
NCT06521307 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Arginase Inhibition in Ischemia-reperfusion Injury
NCT02009527 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Dexmedetomidine on Kidney Function in EVAR
NCT04766047 ·Status: UNKNOWN ·Phase: NA
-
N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery
NCT00188630 ·Status: COMPLETED ·Phase: PHASE3
-
N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement
NCT01704482 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients
NCT00161369 ·Status: COMPLETED
-
High-Dose N-Acetylcysteine in Cardiac Surgery
NCT00332631 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis
NCT00173706 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Renal Failure Post Liver Transplantation
NCT01907061 ·Status: COMPLETED ·Phase: NA
-
Citrate Pharmacokinetics and Regional Citrate Anticoagulation in CRRT
NCT00948558 ·Status: UNKNOWN
-
Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury
NCT02701127 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
RCT to Evaluate the Renal Protective Effects of Remote Ischaemic Preconditioning in Peripheral Angioplasty
NCT02054871 ·Status: UNKNOWN ·Phase: NA
-
Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography
NCT01144091 ·Status: WITHDRAWN ·Phase: NA
-
N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome
NCT03346681 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
N-Acetylcysteine and Arginine Administration in Diabetic Patients
NCT00569465 ·Status: TERMINATED ·Phase: PHASE4
-
Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery
NCT00211653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Papaverine on Renal Artery Blood Flow Volume
NCT04162834 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
NCT03440268 ·Status: UNKNOWN ·Phase: PHASE4
-
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock?
NCT04589546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3